Helicobacter Pylori Diagnostics Market continues to grow rapidly with rising incidences of infectious diseases combined with rising awareness regarding the same
Market Overview
Helicobacter pylon is a genus of gram-positive and spiraling microorganisms. It is responsible for infection in the stomach. Helicobacter pylon can cause dysentery and diarrhea. It has also been associated with peptic ulcers and other bowel disorders. These diagnostic techniques include non-infectious conditions like recurrent acute peptic ulcer, non-ulcer dyspeptic ulcers, malignancies, and other conditions including candida, Helicobacter pylon (H.pylori), Helicobacter pylori (H.pylori), and Staphylococcus aureus (S.aureus). Healthcare infrastructure is developing at a rapid pace and adopting new diagnostic tools to facilitate diagnosis and treatment. This Diagnostic Medical Equipment or DMECs are used to screen patients, take blood samples, perform physical examination and culture of growths, and analyze immune and inflammatory parameters.
Helicobacter Pylori Diagnostics Market To Surpass US$ 807.4 Million By 2028 – Coherent Market Insights
Get COVID-19 Impact Analysis with This Sample Report – https://www.coherentmarketinsights.com/insight/request-sample/1874
Market Drivers
Increasing prevalence of infectious diseases is expected to drive growth of the global helicobacter pylori diagnostics market during the forecast period. The prevalence of infectious diseases such as HIV/AIDS and influenza has increased significantly. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2019, around 38 million people were suffering from HIV/AIDS across the globe, of which around 36.2 million were adults and 1.8 million were children aged 15 years and below. According to the World Health Organization (WHO), in 2016, around 250 million people were living with Hepatitis B with around 10.5% of them aware of their infection. H. pylori testing is used to detect infection and evaluate potential treatment options. Hence, such factors are expected to drive growth of the global helicobacter pylori diagnostics market during the forecast period.
However, stringent regulatory policies are expected to restrain growth of the global helicobacter pylori diagnostics market during the forecast period.
To Get Industry Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1874
Impact of COVID-19 Pandemic
Since the outbreak of COVID-19 pandemic in China, the demand for helicobacter pylori diagnostics has increased massively. With growing consumer preference for direct-to-consumer testing, the adoption of H. pylori testing witness significant growth during the pandemic. However, temporary disruption in the global supply chain industry due to nationwide lockdown policies and regulations on physical distancing has negatively impacted the market growth. Furthermore, growing consumer awareness regarding diseases is expected to accelerate market growth in the near future.
Key Takeaways
- The global helicobacter pylori diagnostics market is expected to witness significant growth, registering a CAGR of 7.1% over the forecast period. This is owing to rising awareness regarding infectious diseases among people.
- Among regions, North America is expected to witness significant growth in the global helicobacter pylori diagnostics market over the forecast period. This is owing to increasing prevalence of helicobacter pylori infections across the region. According to the Centers for Disease Control and Prevention (CDC), the prevalence of helicobacter pylori infection in the U.S. is around 35%-40% annually.
- Furthermore, Asia Pacific is expected to register a robust growth rate, owing to improving healthcare facilities in emerging economies such as China and India.
- Key players operating in the global helicobacter pylori diagnostics market are Thermo Fisher Scientific, Bio-Rad Laboratories, Quest Diagnostics Incorporated, F. Hoffmann-La Roche, Meridian Bioscience, Epitope Diagnostics, Inc., Exalenz Bioscience Ltd, and CerTest BIOTEC.
To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1874
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Disease Indication
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Industry Trends
- Epidemiology
- PEST Analysis
- PORTER’S Five Forces
- Market Dynamics
- Global Helicobacter Pylori Diagnostics Market, By Test Type, 2016 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Invasive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2026, (US$ Million)
- Immunoassay
- Rapid Urease Test
- Histology
- Non-Invasive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2026, (US$ Million)
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- Introduction
- Global Helicobacter Pylori Diagnostics Market, By End User, 2016–2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837